0001593968-23-001051.txt : 20230627
0001593968-23-001051.hdr.sgml : 20230627
20230627121442
ACCESSION NUMBER: 0001593968-23-001051
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230623
FILED AS OF DATE: 20230627
DATE AS OF CHANGE: 20230627
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HO WILLIAM
CENTRAL INDEX KEY: 0001400901
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38997
FILM NUMBER: 231045194
MAIL ADDRESS:
STREET 1: 561 ECCLES AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: RAPT Therapeutics, Inc.
CENTRAL INDEX KEY: 0001673772
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473313701
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 561 ECCLES AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 489-9000
MAIL ADDRESS:
STREET 1: 561 ECCLES AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: FLX Bio, Inc.
DATE OF NAME CHANGE: 20160504
4
1
primary_01.xml
PRIMARY DOCUMENT
X0407
4
2023-06-23
0001673772
RAPT Therapeutics, Inc.
RAPT
0001400901
HO WILLIAM
C/O RAPT THERAPEUTICS, INC.,
561 ECCLES AVENUE
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
Chief Medical Officer
false
Common Stock
2023-06-23
4
M
false
920
12
A
23329
D
Employee Stock Option (right to buy)
12
2023-06-23
4
M
false
920
0
D
2029-10-29
Common Stock
920
2301
D
Includes 1,417 shares acquired by Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on April 28, 2023.
Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.
/s/ Rodney Young, Attorney-in-Fact for William Ho
2023-06-27